by The medical radiation shielding market comprises radiation protection barriers and screens that play an imperative role in protecting patients and medical personnel from harmful radiation during diagnostic and therapeutic procedures involving X-rays, gamma rays, and other types of ionizing radiation. Medical radiation shielding products such as barrier panels, ceiling mounts, cabinetry, aprons, thyroid shields help block radiation and enable safe handling of radioactive materials in departments like radiology, cardiology, and oncology.
The Global Medical Radiation Shielding Market Trends is estimated to be valued at US$ 1.70 Bn in 2024 and is expected to exhibit a CAGR of 4.8% over the forecast period 2024 to 2031.
Key Takeaways
Key players operating in the medical radiation shielding market are Marswell Group of Companies, Mirion Technologies, Inc., Esco Micro Pte. Ltd., MAVIG GmbH., Burlington Medical, Gaven Industries, Inc., Nelco, Inc., Marshield, Radiation Protection Products, Inc., Ultraray, Lemer Pax, Berthold Technologies GmbH & Co.KG, SDS Specialist Door Solutions, Scanflex Medical AB, Veritas Medical Solutions LLC, Amray Radiation Protection, ProTechMed. Growing cases of cancer globally have boosted the demand for advanced diagnostic and therapeutic procedures involving radiation, which is a key factor driving the medical radiation shielding market. Moreover, with increasing awareness about radiation safety, healthcare facilities are upgrading existing shielding infrastructure and adopting new radiation safety norms.
Key players are expanding their geographical presence through partnerships and acquisitions to leverage opportunities in emerging countries in Asia Pacific and Latin America. For instance, Marswell Group acquired VanLandschoot Medical Engineering in 2021 to strengthen its footprint in European markets.
Market Key Trends
One of the key trends gaining traction in the Medical Radiation Shielding Market Trends is the growing adoption of lead-free and recycled shielding materials. Traditional lead-based radiation barriers pose environmental and health hazards. Hence, manufacturers are developing eco-friendly alternatives like tungsten and bismuth compounds with equivalent attenuation properties. Additionally, with rising radiation waste volumes, key players are recycling discarded shielding products to reduce material footprint and costs. Overall, innovation in green and sustainable shielding solutions will remain a key differentiator in the highly regulated medical radiation shielding industry.
Porter’s Analysis
Threat of new entrants: Low cost of production and well-established distribution channels lower entry barriers however existing players have strong brand recognition and relationships.
Bargaining power of buyers: Large healthcare facilities and hospitals have significant bargaining power due to their purchasing volume. However specialized needs limit impact of power on pricing.
Bargaining power of suppliers: Few manufacturers globally supply specialized materials like lead which increases supplier power however competition ensures fair prices.
Threat of new substitutes: Limited substitutes exist for radiation shielding due to strict compliance and safety standards in medical industry. New materials pose minimal threat.
Competitive rivalry: Intense competition exists among top manufacturers on pricing and product innovation. Market share grows through expansion into new applications and geographies.
North America
North America holds the largest share of the medical radiation shielding market owing to rising incidence of cancer, increasing usage of nuclear medicine scans and presence of major market players in the region. The United States alone accounts for over 90% market share in the region.
Asia Pacific
Asia Pacific registers the fastest growth due to growing healthcare expenditure, increasing adoption of medical diagnostic techniques and expanding patient pool in countries like China and India. Favorable government initiatives to modernize healthcare infrastructure also support regional market growth.
Germany, United Kingdom and France collectively dominate the Europe medical radiation shielding market. Presence of large cancer research institutes and radiotherapy departments at hospitals drives demand for shielding products. However stringent regulations around radiation safety add to overall costs.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it.
